Overview

In this volume the authors explain the provisions of the Convention on Biological Diversity (CBD) on access and benefit-sharing, the effect of national laws to implement these, and aspects of typical contracts for the transfer of materials. They provide a sector-by-sector analysis of how genetic resources are used, the scientific, technological and regulatory trends and the different markets for products using biotechnology.

Full Product Details

9781853839412

Table of Contents

Reviews

'Written by two of the world's leading authorities on the commercial use of biodiversity, this book is an invaluable resource and guide for further research. It is as practical as it is informative and should be in the hands of everyone interested in the state and fate of the world's living resources' Professor Calestous Juma, Harvard University 'Full of examples from which we can learn... this will be an invaluable resource to policy-makers, organizations studying and creating uses for genetic resources and the companies which wish to develop them' from the Foreword by Professor Sir Ghillean Prance, ex-Director, Kew Gardens and Sir Richard Sykes, ex-Chairman, Glaxo Wellcome

Author Information

Kerry ten Kate is Policy Adviser for the Directorate of, and Sarah Laird is Independent Consultant for the Convention on Biodiversity Unit at, the Royal Botanic Gardens, Kew

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available